News

PRESS RELEASE: The Pershing Square Sohn Cancer Research Alliance Now Accepting Applications for the 2017 Prize for Young Investigators in Cancer Research

The Pershing Square Sohn Cancer Research Alliance (PSSCRA) today announced the opening of applications for its Prize for Young Investigators in Cancer Research. The prize of $200,000 per year for up to three years is awarded annually to at least five New York City-based scientists, enabling them to continue to pursue explorative and high-risk/high-reward research at a stage when traditional funding is lacking.

Read More

PRESS RELEASE: The Pershing Square Sohn Cancer Research Alliance announces 2016 winners

The Pershing Square Sohn Cancer Research Alliance (“the Alliance”) today announced seven winners of the third annual Pershing Square Sohn Prize for Young Investigators in Cancer Research (“the Pershing Square Sohn Prize”). Each will receive $200,000 in funding per year for up to three years to enable them to continue to pursue explorative and high-risk/high-reward research.

Read More

The Pershing Square Sohn Cancer Research Alliance Now Accepting Applications for the 2016 Prize for Young Investigators in Cancer Research

NEW YORK, Oct. 1, 2015 /PRNewswire-USNewswire/ — The Pershing Square Sohn Cancer Research Alliance (PSSCRA) today announced the opening of applications for its Prize for Young Investigators in Cancer Research.

Read More

PRESS RELEASE: Damon Runyon, Sohn Conference Foundations Name 4 New Pediatric Cancer Research Fellows

Exceptional young scientists receive prestigious awards to tackle cancers in children and young adults

Read More

PRESS RELEASE: New York City Based Scientists Awarded Funding For Their Innovative Work in Cancer Research by the Pershing Square Sohn Cancer Alliance

The Pershing Square Sohn Prize winners are making bold advances in research for leukemia, lymphoma, melanoma, pancreatic, prostate, skin, lung, and breast cancer

Read More

PRESS RELEASE: Applications Open for the 2015 Pershing Square Sohn Prize for Young Investigators in Cancer Research

New York, October 2, 2014– The Pershing Square Sohn Cancer Research Alliance (PSSCRA) today announced the opening of applications for its Prize for Young Investigators in Cancer Research. The prize of $200,000 per year for up to three years is awarded annually to five New York City-based scientists, enabling them to pursue cutting-edge research at … Continued

Read More

PRESS RELEASE: Damon Runyon, Sohn Conference Foundations name 3 new pediatric cancer research fellows

New York, Memphis, Boston scientists receive prestigious awards to tackle cancers in children and young adults New York, NY (June 20, 2014) – The Damon Runyon Cancer Research Foundation has named three outstanding young scientists as recipients of the prestigious Damon Runyon-Sohn Pediatric Cancer Research Fellowship Award, committing nearly $625,000 to help address a critical … Continued

Read More

2014 Pershing Square Sohn Prize Winners Announcement Media Coverage

The Pershing Square Sohn Cancer Research Alliance announced the 2014 Prize winners.  Below is a list of all of our media coverage for the announcement.

Read More

Lloyd Trotman receives Pershing Square Sohn Prize for Cancer Research

Award encourages young investigators to take risks in search of a cure Cold Spring Harbor, NY – The Pershing Square Sohn Cancer Research Alliance is honoring Lloyd Trotman, Associate Professor at Cold Spring Harbor Laboratory (CSHL). Trotman will receive one of six prizes for Young Investigators in Cancer Research, which seeks to fuel innovative scientific … Continued

Read More

Press Release: Inaugural Pershing Square Sohn Prize Awarded to Six Young Scientists in New York City to Further Innovative Cancer Research

The Pershing Square Sohn Cancer Research Alliance today announced the winners of the inaugural Pershing Square Sohn Prize for Young Investigators in Cancer Research. Awarded to six New York City-based scientists at the Sohn Investment Conference, the Prize winners will each receive $200,000 per year for up to three years to enable them to pursue cutting-edge research at a stage when traditional funding is lacking.

Read More